Today's Date: April 1, 2023
Multi Image Group Proudly Announces New ESOP Making the Company 100 Percent Employee Owned   •   ALLIANZ DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against All   •   PG&E's 'Sustainability Bond' Transaction to Support Investments in Grid Resilience and Carbon Reduction   •   RYVYL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against RYVYL   •   Bass Named Women In Trucking Association's 2023 Driver of the Year   •   BLOCK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Block   •   160 Driving Academy Celebrates Women's History Month   •   Realty Income Publishes Third Annual Sustainability Report   •   The Religious Forum of Boao Forum for Asia 2023 Media Meeting Concludes Successfully   •   Why We Need to Ban ChatGPT in Elementary Schools   •   REATA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the   •   TGT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Target Corp. Investors with Substantial Losses Have Opp   •   REDWIRE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and D   •   HONDA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Honda   •   Learning Without Tears Scores Big in 2023 EdTech Awards   •   INVIVYD DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inv   •   CONCENTRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Concent   •   Coloring the World with Kindness on National Crayon Day!   •   BEST-EVER FIRST QUARTER AND MARCH SALES FOR KIA AMERICA   •   FSD Pharma Announces Filing of Year-End 2022 Results
Bookmark and Share

Native Americans Shortchanged By Medicare

 PRINCETON, NJ — While Native Americans have the highest per capita incidence of diabetes in the United States, aid for medical needs and health care for Native Americans is significantly underfunded. Indian Health Services, the division of U.S. Health and Human Services that focuses on the concerns of Native Americans, receives approximately $2,000 per person per year, while Medicare is funded at more than $7,000 per person per year and Medicaid is financed at nearly $4,000 per person per year.¹

The risk for diabetes is more than twice as high in Native Americans than in non-Hispanic whites.² And, the consequences of poor diabetes control, including kidney disease, blindness, and limb amputations, are devastating to Native Americans. For example, the rate of diabetes-related kidney failure is 3.5 times higher among Native Americans than in the general U.S. population.³

Other issues related to resources and economics also contribute to the disparity. In some cases, basic medical supplies like gauze and antibiotic ointments are in short supply. Due to the remote locations of many Native American communities, access to general practitioners and diabetes care specialists is limited.

“Native Americans face particularly unique challenges that inhibit their ability to obtain adequate diabetes education and treatment,” said Jerzy Gruhn, president of Novo Nordisk Inc., a leader in diabetes care. “Novo Nordisk is working to help ethnic communities hit hard by diabetes through legislative efforts and strategic partnerships with organizations.”

The disparity in diabetes prevention and care in racial and ethnic communities is examined in the fourth issue of the Novo Nordisk BlueSheet. Highlighted in this issue are specific advocacy efforts that address the disparity. Also featured are interviews with Dr. Donald Warne, director of the Office of Native American Health at Sanford Health, about how the office serves nearly 300,000 Native Americans in 28 tribes where the prevalence of diabetes reaches 50 percent in some communities, and with one Native American woman living with diabetes about what she’s doing to take control of managing her disease.

About Novo Nordisk

 

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk’s B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.


STORY TAGS: NATIVE AMERICAN, INDIAN, NATIVES, MINORITY, CIVIL RIGHTS, DISCRIMINATION, RACISM, DIVERSITY, RACIAL EQUALITY, BIAS, EQUALITY



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News